U.S. Laboratories
U.S. Laboratories

Infection Control

At U.S. Laboratories, we believe in providing our clients with the information you need to succeed. That's why our consultant staff monitors metrics each quarter for trending of both lab x-ray and ultrasound exam results to help you identify areas needing quality improvement.

Our consulting staff attends your quarterly infection control meeting. At this time, agenda items are reviewed as well as new recommendations, regulations and guidelines. Representation at your quarterly meetings includes the following:

Infection Control Report with statistical analysis when you submit your line listing surveillance data to us seven days prior to your meeting. We also provide data in various graph formats.

View two sample graphs.

  • An on-site review of infection control line listing surveillance data, (for first-time users).
  • Access to CDC and McGeer’s guidelines.





Privacy Statement Notice of Privacy Practices (pdf) Our Code of Conduct (pdf)